Christodoulou, R.C.; Vamvouras, G.; Sarquis, M.D.; Petrou, V.; Papageorgiou, P.S.; Rivera, L.; Morales, C.; Rivera, G.; Vassiliou, E.; Solomou, E.E.;
et al. Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer’s Disease. Biomedicines 2025, 13, 2632.
https://doi.org/10.3390/biomedicines13112632
AMA Style
Christodoulou RC, Vamvouras G, Sarquis MD, Petrou V, Papageorgiou PS, Rivera L, Morales C, Rivera G, Vassiliou E, Solomou EE,
et al. Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer’s Disease. Biomedicines. 2025; 13(11):2632.
https://doi.org/10.3390/biomedicines13112632
Chicago/Turabian Style
Christodoulou, Rafail C., Georgios Vamvouras, Maria Daniela Sarquis, Vasileia Petrou, Platon S. Papageorgiou, Ludwing Rivera, Celimar Morales, Gipsany Rivera, Evros Vassiliou, Elena E. Solomou,
and et al. 2025. "Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer’s Disease" Biomedicines 13, no. 11: 2632.
https://doi.org/10.3390/biomedicines13112632
APA Style
Christodoulou, R. C., Vamvouras, G., Sarquis, M. D., Petrou, V., Papageorgiou, P. S., Rivera, L., Morales, C., Rivera, G., Vassiliou, E., Solomou, E. E., & Papageorgiou, S. G.
(2025). Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer’s Disease. Biomedicines, 13(11), 2632.
https://doi.org/10.3390/biomedicines13112632
